MonoSol Rx, Par Pharmaceutical sales and marketing update

MonoSol reacquired from Par's Strativa Pharmaceuticals subsidiary U.S. rights to Zuplenz ondansetron oral soluble film. In 2008, Par acquired exclusive, U.S. commercialization rights to the selective...